chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report has been received from a registered nurse concerning a patient of unknown age and gender. The patient's concurrent conditions and pertinent medical history were not reported. On 27-APR-2016, the patient was inadvertently vaccinated with an improperly stored dose of VAQTA (lot # L023936 with an expiration date of 15-MAR-2017), (strength, dose and route of administration were not provided). The vaccine was exposed to -2.2 C of temperature with a time frame of 1 hour. There was no concomitant therapy reported. No adverse effects were reported. Additional information is not expected since there was no consent to follow up.
pt states that she felt normal the day she received the vax.  The next day she woke up feeling sweaty and clammy.  She got nauseated and started vomiting.  She felt weak and light headed like she was going to pass out.  She vomited for about an hour and then when that left all of the other symptoms left as well.  She has not contacted her PCP at this time.
Myocarditis. Pain in chest, left arm and both sides of jaw. Lasted for about 10 minutes.
The patient came to the pharmacy to receive the second dose and she said her arm was still tender after 73 days. She said a scab had just fallen off from it and her arm appeared slightly red. She did not get the second vaccine because I told her I would feel more comfortable after she was no longer having symptoms. She was upset by this and ended up leaving the pharmacy. She also told me she was not very concerned by her reaction to it.
The pt complained of edema extending to the right elbow. Inflammation extending to right elbow, and itching at the site of injection.
This spontaneous report as received from a certified medical assistant refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history, concurrent conditions and drug reactions or allergies was reported. On an unknown date, the patients were vaccinated with improperly stored doses of (Merck) VARIVAX, lot number L001325 and expiry date: 13-JAN-2017, (dose, route of administration and injection site were not provided). No concomitant medications were reported. No adverse effects were reported. There was no product quality issue reported. Follow-up information has been received on 03-AUG-2015 informing that all telephone attempts to obtain follow-up information have been unsuccessful. Follow-up information has been received on 05-AUG-2015 from the certified medical assistant via telephone call. The Certified Medical Assistant reported that she would have to research the request made for patient identifiers, lot number, expiration date and dates of vaccination. Follow-up information has been received from the medical assistant's clinic on 22-OCT-2015, regarding a 12-month-old patient of unknown gender. On 22-JUN-2015, the patient was vaccinated with improperly stored dose of (Merck) VARIVAX lot number was confirmed as L001325 with an expiry date of 13-JAN-2017. This is one of several reports received from the same reporter. Additional information has been requested. Patient's details, suspect details, event information and narrative were updated.
Want to report late/extended menstrual cycle after getting Pfizer/Biontech vaccine.
Vaccinated in Apr2021. As of now I have test positive for COVID-19 as of 11Jul2021; Vaccinated in Apr2021. As of now I have test positive for COVID-19 as of 11Jul2021; This is s spontaneous report from a contactable consumer. This consumer (patient) reported that the 27-year-old patient of an unspecified gender received first dose of bnt162b2 (BNT162B2, Covid-19 Vaccine), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single, dose 2 via an unspecified route of administration on Apr2021 (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.  The patient experienced vaccinated in apr2021. as of now i have test positive for covid-19 as of 11jul2021 on an unspecified date with outcome of unknown , vaccinated in apr2021. as of now i have test positive for covid-19 as of 11jul2021 on 11Jul2021 with outcome of unknown.  Seriousness criteria of the events was medically significant. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 11Jul2021. The clinical course was reported as follows: I am 27 years old and was fully vaccinated in Apr2021. As of now I have test positive for COVID-19 as of  11Jul2021.I'm interested in participating for the Pfizer Booster shot.  Information on the lot/batch number has been requested.
Staff member received Moderna vaccine around 11:45am on 02/05/2021. Reported to management around 3pm her lips were swelling, a tingling  around her mouth was felt.
Fever max of 100.6, headache, body aches, fatigue, dizziness, nausea
After receiving the Moderna Covid vaccine, patient passed out while waiting for his 15 minutes observation. He fell off his chair and hit his nose on the floor/object. He started bleeding for a few minutes but became stabilized. 15 minutes later, he felt well enough to slowly get up and carefully walk around the pharmacy. He reported feeling fine and went home. Later on the day, I contacted him and he reported doing fine.
Patient became cyanotic, felt warm in the head area. Then began shaking which lasted 15-20 minutes and patient became real warm. This happened on Thursday night. Repeated twice on Friday and once on Sunday. Mother also reported that temperature on Thursday night was 104 F. Did not take infant to ER.
101 fever lasted 15 hours Chills lasted 15 hours Overly tired lasted 30 hours Migraine lasted 30 hours Stuffy nose lasted 12 hours Whole body aches lasted 12 hours Frequent urinating  lasted 9 hours
patient had a stroke-which caused brain to bleed patient has no use of right side of body, loss of speech, confined to bed, had to get feeding tube, & seizures
This spontaneous report as received from a nurse refers to a 2 patients of unknown age and gender. The patient's medical history and concurrent conditions were not provided. On an unknown date, the patients were vaccinated with improperly stored dose of GARDASIL 9 (dose, frequency, route of administration and indication were not reported, lot # M004116, with expiration date: 12-OCT-2017). Concomitant medications were not reported. No adverse symptoms reported. This is one of several reports received from the same reporter. Additional information has been requested.
Tinnitus in both ears since day after vaccination. April 15 left ear tinnitus mostly subsided but right ear still noticable and preventing sleep.
This spontaneous report was received from a pharmacist regarding a 78 year old female patient. The patient's medical history included shingles. The patient had unspecified reactions to quinapril and penicillin on unspecified dates. On 18-APR-2016, the patient was vaccinated with ZOSTAVAX 0.65 ml once, subcutaneous, lot # L034727, expiry date: 09-DEC-2016 as a precaution for shingles. On approximately 20-APR-2016 ("with in two days afterwards"), the patient experienced muscle soreness and joint pain. The pharmacist reported that, the patient was currently taking CRESTOR (dose, strength, route, frequency unknown) initiated on an unspecified date for an unspecified indication and "this could be causing muscle soreness". The reporter stated that, the patient sought medical attention by contacting another pharmacist however she did not contact her physician. The patient did not receive any treatment for the events. The outcome of muscle soreness and joint pain was unknown. Causality was not provided by the reporter. Additional information has been requested.
urticaria; after four days rashes all over body; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (urticaria) and RASH (after four days rashes all over body) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (urticaria) and RASH (after four days rashes all over body). At the time of the report, URTICARIA (urticaria) and RASH (after four days rashes all over body) outcome was unknown.            No concomitant medications provided. No treatment medications provided.
This spontaneous report as received from a nurse practitioner refers to a 57 year old female patient. Concurrent condition included allergy to sulfa, cephalosporins and for eggs. On 10-DEC-2012 the patient was vaccinated with PNEUMOVAX23. The lot number of the dose of vaccine was illegible on the scanned copy that the nurse practitioner has available, but she states that the lot number appears to be either H018940 or H018440. The dose and route of administration were not provided. No other co-suspects were reported. No concomitant medications were reported. On 10-DEC-2012 the patient experienced soreness from the injection site to her axilla. On 11-DEC-2012 the patient experienced rigors and chills and fever of 100.8. On 12-DEC-2012 the injection site looked like she was developing cellulitis. The nurse practitioner prescribed doxycycline and ADVIL and will continue to monitor the patient. The outcome of soreness from the injection site to her axilla, injection site looks like she is developing cellulitis, fever of 100.8 and rigors and chills was reported as not recovered/not resolved. The relatedness for soreness from the injection site to her axilla, injection site looks like she is developing cellulitis, rigors and chills and fever of 100.8 is unknown for PNEUMOVAX23. Additional information has been requested.
Rash occurred a few hours after receiving MENACTRA. Widespread urticarial rash including face. Dexamethasone sodium phosphate 6mg IM administered on 5/24/11. Prednisone 10mg pack po.
Patient is a 85 y.o. male with history of MGUS, Peripheral Neuropathy, Glaucoma, CAD with DES to LAD and Cx in 2009, Ischemic Cardiomyopathy, Paroxysmal Afib on sotalol and xarelto, PVCs, HTN, HLD, Pacemaker in situ, Hypothyroidism  presented to the Medical Center with Rectal Bleeding.  Hospitalization was complicated by acute respiratory failure 2/2 HCAP/COVID.   Acute hypoxic respiratory failure  Likely Healthcare Associated Pneumonia Covid-19 Virus Infection Date of onset of symptoms: 12/13/22 Symptoms present: congestion, SOB, hypoxia Date of covid positive test: 12/13/22 Vaccination status: vaccinated Imaging: CXR - bilateral airspace opacities concerning for infection Oxygen requirements on admission: RA   Current oxygen requirements: 2L Medical therapy: steroids, Cefepime, remdesivir Consultants following: None Anticipated special isolation end date: 12/23/22 MRSA probe negative Pt. Fortunately passed his home O2 eval does not qualify for oxygen Change Cefepime to Levaquin for 2 more days to complete abx discharge with Decadron to complete 10d total therapy   Acute Upper GI Bleed Presented w/ large bloody BM and an episode of Tarry BM Enhanced by Xarelto Hgb 9.3 on admit (Hgb 14 a month ago) S/p K-centra at OSH GI follows. EGD with non bleeding gastric ulcers and clotted blood in cardia and fundus. Per GI, PPI BID for 2 months, repeat EGD in 2 months. Check H. Pylori stool antigen test and treat if positive.  HGB 8.7,stable for 48 hrs therefore restarted home xarelto 12/12/22 (Discussed with GI) H/h stable Restarted ASA as hgb has been stable   Syncope Could be related to Vasovagal and GI bleed and hypotension Check Orthostats when able BP already improving Monitor on Tele   Paroxysmal Afib  Home Regimen: Sotalol and Xarelto Continuee Sotalol and Xarelto    Fall In setting of syncope CXR with bibasilar atelectasis CT head non acute CT C-spine: Non acute but with multilevel spondylosis CT T/L Spine: non acute but with degen changes w/o significant stenosis team assessed and signed off PT/OT  re consulted and has no needs   Hypothyroidism TSH 2.81 Continue synthroid   HTN Initially held home BP meds due to hypotension Now hypotension resolved, resume home sotalol If BP continued to trend up, will restart home lisinopril  BP controlled without lisinopril Resume Norvasc on discharge   Hx of CAD s/p DES Holding ASA given above Iresume ASA on discharge as Hgb has been stable Check H&H o/p  Chest Pain Troponin on admit neg x 2 EKG on admit w/o signs of acute ischemia Vague episode 12/10 night and EKG w/o signs of ischemia Monitor on Tele, follow up with Cardio o/p
This spontaneous report was received from a registered nurse and refers to a 39 year old female patient. The patient's concurrent conditions and medical history were not reported. On 19-OCT-2016, the patient was vaccinated with an improperly stored dose of VARIVAX lot # M008173 with expiration date of 16-FEB-2018 (dose, route and frequency were not reported) for prophylaxis. Again on 18-JAN-2017, she was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(manufacturer unknown) lot # M018436 with expiration date of 13-APR-2018 (dose, route and frequency were not reported) reconstituted with properly stored sterile diluent (MRK) for prophylaxis. No adverse effects were reported. Both lots underwent a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 22 days (for lot # M008173) and 113 days (for lot # M018436). It was reported that there was no need to repeat vaccine. No previous temperature excursion. The call was not because of a "data logger". There was no Product Quality Complaint (PQC) involved in this case. No further information was provided. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1705USA014053.
This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 20Apr2021 at 12:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included duloxetine hydrochloride (CYMBALTA) and esomeprazole sodium (NEXIUM); both for an unknown indication from an unknown date and unknown if ongoing. The patient previously took promethazine (PHENERGAN) and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8721) via an unspecified route of administration in the right arm on 30Mar2021 at 12:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021, the patient experienced headache, fatigue, nausea and diarrhea. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, fatigue, nausea and diarrhea were unknown at the time of this report. No follow-up attempts are possible. No further information is expected.
approx 4 hrs following vax pt began high-pitched crying; mom unable to console pt; p/several minutes mom called clinic advised mom to given APAP again; went to MD dx rxn to DTP; crying stopped late evening 30NOV93;
Shingrix shot#1- allergic reaction beginning on the day after the shot. Chills, fever, swollen injection area, upset stomach, throat closing. Continued to get worse for two days. Went to doctor. I was told I was having reaction to immunization. For two days I kept trying to clear my throat, thinking I had something caught in my throat. Dr said it was my throat closing off.
Information has been received from a physician concerning a female who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (dose, route and lot number not reported).  The physician reported that the patient had a swollen arm after receiving the vaccine.  The patient recovered that the patient had a swollen arm after receiving the vaccine.  The patient recovered from the event on an unspecified date.  The patient was seen by the physician.  Follow up information has been received from a physician concerning a 12 year old female with no pertinent medical history reported, no known drug allergies and no illness at the time of vaccination who 09-MAR-2009 was vaccinated SC with a dose of VARIVAX (Merck) (dose not reported, lot number 660337/0098X).  The physician reported that the patient's arm was red and swollen on 11-MAR-2009.  On 12-MAR-2009, the patient called again and the symptoms persisted.  She was seen in office on 13-MAR-2009 and had minimal edema and erythema.  The patient recovered from the events on 20-APR-2009.  No lab studies were performed.  No further information is available.
5 days post vaccination Patient noted decreased vis acuity in left eye and anisocoria with the left pupil measuring 6mm and the right 2.5mm. The right appeared normal sized to the patient.  This was assoc. with a mild headache which began 2 hrs after the dilated left pupil  was noted. On exam the pupillary size was as noted. Pt able to read 2 inch print with left eye and news print with right eye. The pupil reacted to light less vigorously than the right and had a slow and minimal consensual reaction to light shined in the right eye.
hard time keeping blood sugar up; diarrhea; Hives; This is a spontaneous report from a contactable nurse (patient's sister). A 39-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: expiry date: unknown) via an unspecified route of administration, in Dec2020, at a single dose, for COVID-19 immunization. Medical history included diabetic. The patient's concomitant medications were not reported. Registered nurse called regarding COVID-19 vaccine. Her sister who is also a nurse got the vaccine before she did sometime in Dec2020. About 18 hours after receiving the COVID 19 vaccine, her sister got diarrhea and was having a hard time keeping her blood sugar up. The patient did not receive treatment for events diarrhea or the blood sugar. Patient also experienced hives and used Benadryl as treatment. Nurse stated that she has not talked to her; unsure if all of these events resolved or not but thinks the diarrhea was better. Outcome of the event diarrhea was recovering, while for other events was unknown. Seriousness of the events was not provided.  No further information is provided. Information on the lot/batch number has been requested.
Headache, significantly muscle/body aches, joint pain, significant fatigue. Continual, intermittent shooting abdominal pain.
broke up with a rash; really itchy; redness; little itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (little itchy), VACCINATION SITE RASH (broke up with a rash), VACCINATION SITE PRURITUS (really itchy) and VACCINATION SITE ERYTHEMA (redness) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included Lymph node dissection since an unknown date. Concurrent medical conditions included Breast cancer. Concomitant products included CALCIUM and KRILL OIL for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE PRURITUS (little itchy). On 16-Feb-2021, the patient experienced VACCINATION SITE RASH (broke up with a rash), VACCINATION SITE PRURITUS (really itchy) and VACCINATION SITE ERYTHEMA (redness). The patient was treated with CORTISONE for Itching, at a dose of 1 dosage form. In February 2021, VACCINATION SITE ERYTHEMA (redness) had resolved. On 20-Feb-2021, VACCINATION SITE PRURITUS (little itchy), VACCINATION SITE RASH (broke up with a rash) and VACCINATION SITE PRURITUS (really itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
The patient experienced a fever of 103.2F at night for 3 nights. The patient had no other symptoms.
Init visit 5/8 notable for fine pink rash on face, neck arms and trunk as well as enlarged glandular tssue under jaw bilaterally. Tongue slightly swollen,apthious ulcer on tip. Mild cracking lip tissue. Treated with triamcinolone dental paste. 5/9 due to family concern that she was getting worse with more oral/lip swelling, pt examined in ER and given 2 mg Decadron and sent home. 5/9 I again saw her and noted that the lips were now cracked and swollen tongue was a bit more protrusive. Glandular swelling was bout the same. I gave her 6.25 mg of Benadryl here and sent her home on oral decadron 0.5 mg BID for 3 days. 5/13 and noted that the lip and tongue swelling w/improved eat. 5/16 lips healed rash gone NL mood.
3/29/2021 ERS Report: from Vaccination Clinic:  Patient reported symptoms: Per ERS report:  "Pt was walking to car after receiving her COVID-19 vaccine and a syncopal episode. Pt then had seizure like activity for approximately 1 min. Family states that she does have "stress seizures but is not on any anticonvulsants." Vital signs and blood sugar were assessed by onsite paramedic (AMR) and were within normal limits. Pt was then transported to hospital for further care."   ED visit after Covid Vaccine 3/29/2021:  HISTORY OF PRESENT ILLNESS: a 50 y.o. female who presents to the emergency department with history of bipolar and multiple psychiatric conditions including bipolar disorder.  She presents today with episodes of ?seizure? and the desire to not speak to anybody.  She has not been speaking to her husband since Friday and today while she was on the way out from getting a COVID vaccine fell to the floor and having shaking convulsing like episode.  Husband states it lasted for 1 minutes and then resolved.  He states that she has been unwilling to talk to him or medical staff and he does not know what is going on.  He does affirm that she has been complaining about abdominal pain for the last 3 days and they did go to the hospital and have this worked up.  He states that she has no known history of seizures and is not on any medications for this.  CT head normal.  Drug screen normal.  Discharged to home.
had the usual sore arm 1st several day p/vax but on 5APR pain inc to severe;cont to c/o pain & arm & hand became swollen & felt like it was asleep (tingling);also had an episode of vomiting 5APR & 6APR;8APR dad contacted school nurse;